ONTARIO — Avita Health System’s new cancer center will be the first in Ohio to invest in the Varian RapidArc Dynamic technology, a move that promises to enhance cancer treatment precision and reduce ...
AVITA Medical has appointed Cary Vance as Interim CEO following the sudden departure of Jim Corbett, along with a Board reshuffle. The company also announced preliminary third-quarter revenue guidance ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Avita ...
VALENCIA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today announced ...
Avita Medical said its Chief Executive Jim Corbett would be departing. Board chair Cary Vance is expected to succeed Corbett as interim chief executive. Vance will continue as chair, while board ...
BUCYRUS – Avita Health System has announced plans to build a new medical clinic at 307 Hill St. The 15,000-square-foot facility is slated to open in late summer 2026. “Avita has been preparing to ...
AVITA Medical has dropped ~65% since my last article in 03/2023. It has encountered significant reimbursement issues that it expects to resolve as the year unwinds. Strategic decisions and ...
Gift 5 articles to anyone you choose each month when you subscribe. Avita Medical shareholders were left wide-eyed after the dual-listed biotech, known for its spray-on skin technology for burns ...
Avita Health System launched a Drug Repository Program allowing donation and redistribution of unexpired medications to qualifying patients. Patients must be Ohio residents, referred by a medical ...
What is Turbo Avita Lab? Turbo Avita Lab is a cryptocurrency trading platform that analyses the market and automatically places trades using intelligent algorithms. It was created so that anyone, ...
Avita Medical shares declined 20% after quarter first-quarter revenue missed Wall Street's estimates. Shares were trading around $7.47. The stock is down 42% on the year so far. The Valencia, Calif., ...